Webinar
The Criticality of 3D Planning for Successful Structural Heart Therapy — Perspective of an Early Stage Medtech Company
Mass Personalization Summit 2022
About this webinar
Watch this recording to learn about 4C Medical Technologies' experience with 3D planning for structural heart interventions.
What you will learn
- Why 3D planning matters in minimally invasive structural heart interventions
- Where 4C Medical Technologies captured the value of3D planning for product development, regulatory submissions, clinical outcomes, and physician training
- What the step-by-step procedural planning of 4C Medical looks like
Speaker
Saravana Kuma
Saravana Kuma
Vice President of R&D and Operations, 4C Medical Technologies
Saravana Kumar is currently Vice President of R&D and Operations at 4C Medical Technologies, a company developing an innovative solution for the treatment of mitral valve regurgitation. Prior to 4C Medical, Saravana served as Senior Director of R&D and Operations at Conventus Orthopaedics, and led engineering teams at St. Jude Medical for the successful development and commercialization of a transcatheter aortic valve replacement technology. Saravana received his PhD in Mechanical Engineering from the University of Minnesota, his master’s degree from the University of North Carolina, and his bachelor’s degree from the University of Delhi in India.
Share on:
L-103113-01
Mass Personalization Summit 2022
One size fits no one. That’s why mass personalization is crucial to ensure predictable and efficient patient care. Watch recordings from our virtual event to learn how together we can make personalization scalable for a more sustainable future in healthcare.
